cgp 12177 has been researched along with thymidine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bronnikov, G; Houstĕk, J; Nedergaard, J | 1 |
Nishijima, K | 1 |
Bernier, M; Jimenez, L; Jozwiak, K; Toll, L; Wainer, IW; Waleh, N; Woo, AY; Xiao, RP | 1 |
1 review(s) available for cgp 12177 and thymidine
Article | Year |
---|---|
[Study on the highly efficient synthesis and pharmaceutical evaluation of PET radiopharmaceuticals for the clinical application].
Topics: Animals; Chemistry, Organic; Drug Evaluation; Humans; Isotope Labeling; Phosgene; Positron-Emission Tomography; Propanolamines; Radiation Dosage; Radiopharmaceuticals; Thymidine | 2006 |
2 other study(ies) available for cgp 12177 and thymidine
Article | Year |
---|---|
Beta-adrenergic, cAMP-mediated stimulation of proliferation of brown fat cells in primary culture. Mediation via beta 1 but not via beta 3 adrenoceptors.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bucladesine; Cell Division; Cells, Cultured; Cholera Toxin; Colforsin; Cyclic AMP; DNA Replication; Imidazoles; Mice; Mice, Inbred Strains; Norepinephrine; Oxymetazoline; Propanolamines; Receptors, Adrenergic, beta; Thymidine | 1992 |
{Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.
Topics: Adrenergic beta-2 Receptor Agonists; Astrocytoma; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Fenoterol; G1 Phase; Humans; Propanolamines; Thymidine | 2011 |